Live Breaking News & Updates on Poster Discussion

Stay updated with breaking news from Poster discussion. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium

Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , San Francisco , Douglase Onsi , Matthew Deyoung , Meredith Pelster , Msc Sarah Cannon Research Institute , American Society Of Clinical Oncology , Prnewswire Leap Therapeutics Inc , Drug Administration , Leap Therapeutics Inc , Clinical Oncology , Gastrointestinal Cancers , Presentation Details , Sarah Cannon Research Institute , Poster Discussion , Poster Session , Leap Therapeutics , Annual Report ,

Live from ASCO 2023 | Ascentage Pharma Releases Updated Data Showing APG-2449's Potential as a New Treatment for Drug-Resistant NSCLC

/PRNewswire/ Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and. ....

United States , Li Zhang , Western Australia , Hong Kong , Yifan Zhai , Ascentage Pharma , National Reimbursement Drug List , American Society Of Clinical Oncology , Sun Yat Sen University Cancer Center , China National Medical Products Administration , Major National , Md Anderson Cancer Center , Dana Farber Cancer Institute , Poster Discussion , American Society , Clinical Oncology , Principal Investigator , Sun Yat Sen University Cancer , Chief Medical Officer , Lung Cancer , Non Small Cell , Main Board , Stock Exchange , Hong Kong Limited , Major National Rd Projects , Major New Drug Projects ,

Elevation Oncology Highlights First-in-Human Phase 1 SYSA1801 (EO-3021) Clinical Data to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023

/PRNewswire/ Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies. ....

United States , Chunlei Li , Valerie Malyvanh Jansen , Yakun Wang , Elevation Oncology Inc , Corporate Communications Investor Relations , American Society Of Clinical Oncology , Prnewswire Elevation Oncology Inc , Exchange Commission , Group Limited , Drug Administration , American Society , Clinical Oncology , Chief Medical Officer , Elevation Oncology , Chief Scientific Officer , Poster Discussion , Molecularly Targeted Agents , Session Date , Discussion Date , Investigational New Drug , Private Securities Litigation Reform Act , Oncology Investor , Corporate Communications ,

New Natera Data to be Presented at the 2023 ASCO Annual Meeting in 13 Studies Across Multiple Cancer Types

Highlights include oral presentations in Sarcoma and CRC; immunotherapy monitoring data from the Phase 3 EMPOWER-Lung 1 study; updates from the CIRCULATE-Japan study in CRC

. | May 30, 2023 ....

United States , San Carlos , American Society Of Clinical Oncology , Natera Inc , Clinical Laboratory Improvement Amendments , Association Of Tumor , Clinical Oncology , Annual Meeting , Minetta Liu , Poster Discussion , High Rates , Undiagnosed Concomitant Radiographic Recurrences , Oral Presentation , Soft Tissue Sarcoma , Poster Presentation , Clinical Outcomes , Muscle Invasive Bladder Cancer , Multicenter Retrospective Real World , Esophageal Cancer , Informs Maintenance Outcomes , Bile Duct Cancer , Pancreatic Cancer , Thymus Cancer , Breakthrough Device Designations , Nc Stock Exchange , Press Release ,

Antengene To Present Latest Results from TORCH-2 Study of ATG-008 in Advanced Solid Tumors in Poster Discussion at ASCO 2023

/PRNewswire/ Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to. ....

South Korea , United States , Mccormick Place , Hong Kong , Peter Qian , Asia Pacific , Hong Kong Stock Exchange , Prnewswire Antengene Corporation Limited , Company Annual , Eastern Cooperative Oncology Group , Antengene Corporation Limited , American Society For Clinical Oncology Annual Meeting , Antengene Corporation , Mccormick Place Convention Center , Corporation Limited , Clinical Oncology Annual Meeting , Poster Discussions , Poster Discussion , Family Zhang , Chief Medical , Developmental Therapeutics , Discussion Session Date , Central Time , Beijing Time , Cervical Cancer Cohort , Nasopharyngeal Carcinoma ,